RegWardenFDA facility compliance records
Recall

Class II — Mindray DS USA, Inc. dba Mindray North America

Recalling firmMindray DS USA, Inc.
Registered facilityMINDRAY DS USA, Inc. (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonThe MPM included a cardiac ST/Arrhythmia analysis feature which is not cleared for marketing.
ProductDPM 6 Monitor in use with a Multi Parameter Module (MPM). Patient monitor used for monitoring, displaying, reviewing, storing, and alarming of multiple physiological parameters including ECG, arrhythmia detection, ST segment analysis, heart rate (HR), respiration rate (RESP), temperature, pulse oxygen saturation (SpO2), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure (IBP), carbon dioxide (CO2), anesthetic gas (AG), impedance cardiograph (ICG), bispectral index (BIS), cardiac output (C.O.) and respiration mechanics (RM)
Quantity4 units
DistributionUS Nationwide Distribution in the state of OH
Initiated2014-03-05
Classified2014-05-12
Terminated2015-04-27
Recall numberZ-1611-2014
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Mindray DS USA, Inc. dba Mindray North America (Z-1611-2014).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/67932/

Not open yet

Alerts for Mindray DS USA, Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.